featured
High-Dose, High-Frequency Infliximab for Hidradenitis Suppurativa
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
High-Dose, High-Frequency Infliximab: A Novel Treatment Paradigm for Hidradenitis Suppurativa
J Am Acad Dermatol 2019 Oct 04;[EPub Ahead of Print], MH Ghias, AD Johnston, AJ Kutner, RG Micheletti, HD Hosgood, SR CohenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.